{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:20:24Z","timestamp":1783178424477,"version":"3.54.6"},"reference-count":48,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA048625"],"award-info":[{"award-number":["R01 DA048625"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35 GM127303"],"award-info":[{"award-number":["R35 GM127303"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.molpha.2026.100123","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T14:57:12Z","timestamp":1776697032000},"page":"100123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanisms for enhancement of \u03bc-opioid receptor-mediated antinociception in the central nervous system through gallein-dependent modulation of downstream G protein \u03b2\u03b3 subunit signaling"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2517-4037","authenticated-orcid":false,"given":"Jacob A.","family":"Ormes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3099-8812","authenticated-orcid":false,"given":"Alan V.","family":"Smrcka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M.","family":"Jutkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.molpha.2026.100123_bib1","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/MLR.0000000000002181","article-title":"Economic costs of chronic pain-United States, 2021","volume":"63","author":"Guy","year":"2025","journal-title":"Med Care"},{"key":"10.1016\/j.molpha.2026.100123_bib2","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2147\/JPR.S160255","article-title":"Efficacy of opioids versus placebo in chronic pain: a systematic review and meta-analysis of enriched enrollment randomized withdrawal trials","volume":"11","author":"Meske","year":"2018","journal-title":"J Pain Res"},{"issue":"11","key":"10.1016\/j.molpha.2026.100123_bib3","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.tins.2014.07.010","article-title":"Presynaptic long-term depression mediated by Gi\/o-coupled receptors","volume":"37","author":"Atwood","year":"2014","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.molpha.2026.100123_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.919773","article-title":"Opioid receptor-mediated regulation of neurotransmission in the brain","volume":"15","author":"Reeves","year":"2022","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.molpha.2026.100123_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1165261","article-title":"SNAP25 differentially contributes to G(i\/o)-coupled receptor function at glutamatergic synapses in the nucleus accumbens","volume":"17","author":"Manz","year":"2023","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"10.1016\/j.molpha.2026.100123_bib6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1152\/physrev.00021.2009","article-title":"Inwardly rectifying potassium channels: their structure, function, and physiological roles","volume":"90","author":"Hibino","year":"2010","journal-title":"Physiol Rev"},{"issue":"2","key":"10.1016\/j.molpha.2026.100123_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0014-5793(96)00661-8","article-title":"Activation of G protein-coupled inward rectifier K+ channels in brain neurons requires association of G protein \u03b2\u03b3 subunits with cell membrane","volume":"390","author":"Nakajima","year":"1996","journal-title":"FEBS Lett"},{"issue":"6571","key":"10.1016\/j.molpha.2026.100123_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/380255a0","article-title":"Voltage-dependent modulation of N-type calcium channels by G-protein \u03b2\u03b3 subunits","volume":"380","author":"Ikeda","year":"1996","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.molpha.2026.100123_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1124\/mol.115.101600","article-title":"G\u03b2\u03b3 binds to the extreme C terminus of SNAP25 to mediate the action of Gi\/o-coupled g protein-coupled receptors","volume":"89","author":"Zurawski","year":"2016","journal-title":"Mol Pharmacol"},{"issue":"14","key":"10.1016\/j.molpha.2026.100123_bib10","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1007\/s00018-008-8006-5","article-title":"G protein \u03b2\u03b3 subunits: central mediators of G protein-coupled receptor signaling","volume":"65","author":"Smrcka","year":"2008","journal-title":"Cell Mol Life Sci"},{"issue":"5074","key":"10.1016\/j.molpha.2026.100123_bib11","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1126\/science.1325672","article-title":"Role of \u03b2\u03b3 subunits of G proteins in targeting the \u03b2-adrenergic receptor kinase to membrane-bound receptors","volume":"257","author":"Pitcher","year":"1992","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.molpha.2026.100123_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/pr.112.005942","article-title":"Regulation of mu-opioid receptors: desensitization, phosphorylation, internalization, and tolerance","volume":"65","author":"Williams","year":"2013","journal-title":"Pharmacol Rev"},{"issue":"32","key":"10.1016\/j.molpha.2026.100123_bib13","doi-asserted-by":"crossref","first-page":"30219","DOI":"10.1074\/jbc.M302385200","article-title":"Agonist-induced formation of opioid receptor-G protein-coupled receptor kinase (GRK)-G\u03b2\u03b3 complex on membrane is required for GRK2 function in vivo","volume":"278","author":"Li","year":"2003","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.molpha.2026.100123_bib14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1124\/molpharm.122.000541","article-title":"Coincident regulation of PLC\u03b2 signaling by Gq-coupled and \u03bc-opioid receptors opposes opioid-mediated antinociception","volume":"102","author":"Sanchez","year":"2022","journal-title":"Mol Pharmacol"},{"issue":"15","key":"10.1016\/j.molpha.2026.100123_bib15","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cub.2010.06.013","article-title":"Synergistic activation of phospholipase C-\u03b23 by Galpha(q) and G\u03b2\u03b3 describes a simple two-state coincidence detector","volume":"20","author":"Philip","year":"2010","journal-title":"Curr Biol"},{"issue":"2","key":"10.1016\/j.molpha.2026.100123_bib16","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1074\/jbc.M110.198200","article-title":"Synergistic Ca2+ responses by Galphai- and Galphaq-coupled G-protein-coupled receptors require a single PLC\u03b2 isoform that is sensitive to both G\u03b2\u03b3 and Galphaq","volume":"286","author":"Rebres","year":"2011","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.molpha.2026.100123_bib17","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.molcel.2020.10.027","article-title":"Heterotrimeric G protein subunit Galphaq is a master switch for G\u03b2\u03b3-mediated calcium mobilization by Gi-coupled GPCRs","volume":"80","author":"Pfeil","year":"2020","journal-title":"Mol Cell"},{"issue":"18","key":"10.1016\/j.molpha.2026.100123_bib18","doi-asserted-by":"crossref","first-page":"10385","DOI":"10.1073\/pnas.96.18.10385","article-title":"Genetic alteration of phospholipase C \u03b23 expression modulates behavioral and cellular responses to \u03bc opioids","volume":"96","author":"Xie","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5772","key":"10.1016\/j.molpha.2026.100123_bib19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1126\/science.1120378","article-title":"Differential targeting of G\u00df\u03b3-subunit signaling with small molecules","volume":"312","author":"Bonacci","year":"2006","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.molpha.2026.100123_bib20","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/mol.107.041780","article-title":"Small molecule disruption of G protein \u03b2\u03b3 subunit signaling inhibits neutrophil chemotaxis and inflammation","volume":"73","author":"Lehmann","year":"2008","journal-title":"Mol Pharmacol"},{"issue":"9","key":"10.1016\/j.molpha.2026.100123_bib21","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.bbapap.2011.05.010","article-title":"Direct-reversible binding of small molecules to G protein \u03b2\u03b3 subunits","volume":"1814","author":"Seneviratne","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"47","key":"10.1016\/j.molpha.2026.100123_bib22","doi-asserted-by":"crossref","first-page":"12183","DOI":"10.1523\/JNEUROSCI.2326-08.2008","article-title":"A novel G\u03b2\u03b3-subunit inhibitor selectively modulates \u03bc-opioid-dependent antinociception and attenuates acute morphine-induced antinociceptive tolerance and dependence","volume":"28","author":"Mathews","year":"2008","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.molpha.2026.100123_bib23","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1161\/CIRCRESAHA.110.217075","article-title":"Small molecule disruption of G\u03b2\u03b3 signaling inhibits the progression of heart failure","volume":"107","author":"Casey","year":"2010","journal-title":"Circ Res"},{"issue":"23","key":"10.1016\/j.molpha.2026.100123_bib24","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/j.jacc.2014.02.587","article-title":"Simultaneous adrenal and cardiac G-protein-coupled receptor-G\u03b2\u03b3 inhibition halts heart failure progression","volume":"63","author":"Kamal","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.molpha.2026.100123_bib25","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jacc.2017.06.049","article-title":"Pharmacological and activated fibroblast targeting of G\u03b2\u03b3-GRK2 after myocardial ischemia attenuates heart failure progression","volume":"70","author":"Travers","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.molpha.2026.100123_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0076-6879(07)34003-2","article-title":"Analysis and pharmacological targeting of phospholipase C \u03b2 interactions with G proteins","volume":"434","author":"Lehmann","year":"2007","journal-title":"Methods Enzymol"},{"issue":"4","key":"10.1016\/j.molpha.2026.100123_bib27","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/emboj\/20.4.767","article-title":"Evidence that a protein-protein interaction 'hot spot' on heterotrimeric G protein \u03b2\u03b3 subunits is used for recognition of a subclass of effectors","volume":"20","author":"Scott","year":"2001","journal-title":"EMBO J"},{"issue":"11","key":"10.1016\/j.molpha.2026.100123_bib28","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrd.2018.135","article-title":"Targeting G protein-coupled receptor signalling by blocking G proteins","volume":"17","author":"Campbell","year":"2018","journal-title":"Nat Rev Drug Discov"},{"issue":"31","key":"10.1016\/j.molpha.2026.100123_bib29","doi-asserted-by":"crossref","first-page":"10593","DOI":"10.1021\/bi050655i","article-title":"Structural and molecular characterization of a preferred protein interaction surface on G protein \u03b2\u03b3 subunits","volume":"44","author":"Davis","year":"2005","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.molpha.2026.100123_bib30","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/FBP.0b013e32835f3d2f","article-title":"Inhibition of G\u03b2\u03b3-subunit signaling potentiates morphine-induced antinociception but not respiratory depression, constipation, locomotion, and reward","volume":"24","author":"Hoot","year":"2013","journal-title":"Behav Pharmacol"},{"issue":"9","key":"10.1016\/j.molpha.2026.100123_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.molpha.2025.100068","article-title":"Biasing G protein \u03b2\u03b3 subunit downstream signaling enhances the analgesic effects of endogenous opioid receptor agonists during nitroglycerin-induced thermal hypersensitivity","volume":"107","author":"Mohamed","year":"2025","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.molpha.2026.100123_bib32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1124\/molpharm.124.000875","article-title":"Biasing G\u03b2\u03b3 downstream signaling with gallein inhibits development of morphine tolerance and potentiates morphine-induced antinociception in a tolerant state","volume":"106","author":"Sanchez","year":"2024","journal-title":"Mol Pharmacol"},{"issue":"5","key":"10.1016\/j.molpha.2026.100123_bib33","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3390\/biomedicines11051413","article-title":"Epidural and intrathecal drug delivery in rats and mice for experimental research: fundamental concepts, techniques, precaution, and application","volume":"11","author":"Rahman","year":"2023","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.molpha.2026.100123_bib34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/gt.2017.18","article-title":"Efficient CNS targeting in adult mice by intrathecal infusion of single-stranded AAV9-GFP for gene therapy of neurological disorders","volume":"24","author":"Bey","year":"2017","journal-title":"Gene Ther"},{"issue":"8","key":"10.1016\/j.molpha.2026.100123_bib35","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/sj.bjp.0705881","article-title":"Efficacy in CB1 receptor-mediated signal transduction","volume":"142","author":"Howlett","year":"2004","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.molpha.2026.100123_bib36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0026-895X(25)09876-1","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.molpha.2026.100123_bib37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0022-3565(25)10720-9","article-title":"Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice","volume":"262","author":"Welch","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.molpha.2026.100123_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/bja\/81.1.69","article-title":"Epibatidine and pain","volume":"81","author":"Traynor","year":"1998","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.molpha.2026.100123_bib39","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jpain.2008.09.011","article-title":"Methadone antinociception is dependent on peripheral opioid receptors","volume":"10","author":"He","year":"2009","journal-title":"J Pain"},{"issue":"8","key":"10.1016\/j.molpha.2026.100123_bib40","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/aps.2010.82","article-title":"Intracisternal or intrathecal glycine, taurine, or muscimol inhibit bicuculline-induced allodynia and thermal hyperalgesia in mice","volume":"31","author":"Lee","year":"2010","journal-title":"Acta Pharmacol Sin"},{"issue":"2-3","key":"10.1016\/j.molpha.2026.100123_bib41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","article-title":"Intrathecal morphine in mice: a new technique","volume":"67","author":"Hylden","year":"1980","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.molpha.2026.100123_bib42","article-title":"A perspective: neuraxial therapeutics in pain management: now and future","volume":"5","author":"DeAndres","year":"2024","journal-title":"Front Pain Res (Lausanne)"},{"issue":"1","key":"10.1016\/j.molpha.2026.100123_bib43","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41467-018-08162-1","article-title":"Phosphorylation-deficient G-protein-biased mu-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects","volume":"10","author":"Kliewer","year":"2019","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.molpha.2026.100123_bib44","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1002\/art.39673","article-title":"Inhibition of G Protein \u03b2\u03b3 subunit signaling abrogates nephritis in lupus-prone mice","volume":"68","author":"Rangel-Moreno","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"580","key":"10.1016\/j.molpha.2026.100123_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau8491","article-title":"Paroxetine-mediated GRK2 inhibition is a disease-modifying treatment for osteoarthritis","volume":"13","author":"Carlson","year":"2021","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.molpha.2026.100123_bib46","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3390\/cells10030673","article-title":"Cardiac GRK2 protein levels show sexual dimorphism during aging and are regulated by ovarian hormones","volume":"10","author":"Arcones","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.molpha.2026.100123_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1461145710000118","article-title":"Sex differences in the activity of signalling pathways and expression of G-protein-coupled receptor kinases in the neonatal ventral hippocampal lesion model of schizophrenia","volume":"14","author":"Bychkov","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"issue":"37","key":"10.1016\/j.molpha.2026.100123_bib48","doi-asserted-by":"crossref","first-page":"8031","DOI":"10.1523\/JNEUROSCI.0653-18.2018","article-title":"Estrogen regulation of GRK2 inactivates kappa opioid receptor signaling mediating analgesia, but not aversion","volume":"38","author":"Abraham","year":"2018","journal-title":"J Neurosci"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X26000234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X26000234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:08:24Z","timestamp":1783177704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X26000234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":48,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0026895X26000234"],"URL":"https:\/\/doi.org\/10.1016\/j.molpha.2026.100123","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms for enhancement of \u03bc-opioid receptor-mediated antinociception in the central nervous system through gallein-dependent modulation of downstream G protein \u03b2\u03b3 subunit signaling","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molpha.2026.100123","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100123"}}